Clinical Trial Update: Combination of Sotyktu and Enstilar for Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the combination of Sotyktu and Enstilar for plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Enstilar (calcipotriene; betamethasone dipropionate)
• Sotyktu (Deucravacitinib)

Snippet

Sponsor: Psoriasis Treatment Center of Central New Jersey | Conditions: Psoriasis | Phase 4 | Status: COMPLETED